Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006
- PMID: 19616182
- PMCID: PMC4867195
- DOI: 10.1016/j.amjopharm.2009.05.001
Results of a longitudinal analysis of national data to examine relationships between organizational and market characteristics and changes in antipsychotic prescribing in US nursing homes from 1996 through 2006
Abstract
Objective: The aim of this work was to examine the association between organizational characteristics, market characteristics, and changes in antipsychotic medication use in US nursing homes over time.
Methods: This was a longitudinal study comparing antipsychotic use in US nursing homes from 1996 through 2006 using Medicare and Medicaid data (the Online Survey Certification And Reporting system) and US Department of Health and Human Resources Health Resources and Services Administration data (the Area Resource File). The 3 outcomes of interest were increasing, decreasing, or stable use of antipsychotic medications. The primary independent variables were organizational characteristics (eg, for-profit status, chain membership) and market characteristics (eg, Medicaid reimbursement, levels of competition).
Results: Antipsychotic use increased from 16.4% in 1996 to 25.9% in 2006 (P < 0.05). A multinomial generalized estimating equations model, controlling for facility, staffing, and resident factors, suggested that increased antipsychotic use was associated with for-profit facilities (adjusted odds ratio [AOR], 1.58; 95% CI, 1.51-1.65; P < or = 0.001). Decreased antipsychotic use was associated with chain membership (AOR, 0.82; 95% CI, 0.79-0.85; P < or = 0.001), higher levels of competition (AOR, 1.22; 95% CI, 1.16-1.29; P < or = 0.001), and a higher Medicaid reimbursement rate (AOR, 0.88; 95% CI, 0.85-0.92; P < or = 0.001).
Conclusions: Antipsychotic use increased in US nursing homes from 1996 through 2006 and was associated with certain organizational characteristics and market characteristics. Future interventions to reduce antipsychotic use in nursing homes will have to focus on these factors.
Similar articles
-
Antidepressant prescribing in US nursing homes between 1996 and 2006 and its relationship to staffing patterns and use of other psychotropic medications.J Am Med Dir Assoc. 2010 Jun;11(5):320-4. doi: 10.1016/j.jamda.2010.01.007. J Am Med Dir Assoc. 2010. PMID: 20511098 Free PMC article.
-
Assessing approaches and barriers to reduce antipsychotic drug use in Florida nursing homes.Aging Ment Health. 2015;19(6):507-16. doi: 10.1080/13607863.2014.952710. Epub 2014 Aug 28. Aging Ment Health. 2015. PMID: 25166458
-
High Medicaid Nursing Homes: Organizational and Market Factors Associated With Financial Performance.Inquiry. 2019 Jan-Dec;56:46958018825061. doi: 10.1177/0046958018825061. Inquiry. 2019. PMID: 30739512 Free PMC article.
-
Variation in use of antipsychotic medications in nursing homes in the United States: A systematic review.BMC Geriatr. 2017 Jan 26;17(1):32. doi: 10.1186/s12877-017-0428-1. BMC Geriatr. 2017. PMID: 28122506 Free PMC article. Review.
-
Challenge of changing nursing home prescribing culture.Am J Geriatr Pharmacother. 2012 Feb;10(1):37-46. doi: 10.1016/j.amjopharm.2011.12.005. Epub 2012 Jan 20. Am J Geriatr Pharmacother. 2012. PMID: 22264855 Free PMC article. Review.
Cited by
-
Nursing Home Characteristics Associated with Antipsychotic Prescribing After Implementation of the National Antipsychotic Reduction Initiative (ARI).Clin Gerontol. 2024 Oct-Dec;47(5):778-788. doi: 10.1080/07317115.2024.2346906. Epub 2024 May 19. Clin Gerontol. 2024. PMID: 38762776
-
Nursing Home Characteristics Associated with High and Low Levels of Antipsychotic, Benzodiazepine, and Opioid Prescribing to Residents with Alzheimer's Disease and Related Dementias: A Cross-Sectional Analysis.J Am Med Dir Assoc. 2022 Nov;23(11):1780-1786.e2. doi: 10.1016/j.jamda.2022.05.025. Epub 2022 Jun 27. J Am Med Dir Assoc. 2022. PMID: 35772472 Free PMC article.
-
Community, Social, and Facility Factors and Long-stay Antipsychotic Use.Clin Gerontol. 2022 Oct-Dec;45(5):1180-1188. doi: 10.1080/07317115.2022.2063777. Epub 2022 Apr 21. Clin Gerontol. 2022. PMID: 35443876 Free PMC article.
-
Inappropriate Antipsychotic Use: The Impact of Nursing Home Socioeconomic and Racial Composition.J Am Geriatr Soc. 2020 Mar;68(3):630-636. doi: 10.1111/jgs.16316. Epub 2020 Jan 22. J Am Geriatr Soc. 2020. PMID: 31967325 Free PMC article.
-
Current Psychotropic Medication Use and Contributing Factors Among Nursing Home Residents With Cognitive Impairment.Clin Nurs Res. 2021 Jan;30(1):59-69. doi: 10.1177/1054773819838678. Epub 2019 Apr 3. Clin Nurs Res. 2021. PMID: 30943786 Free PMC article. Clinical Trial.
References
-
- Nursing Home Reform Act, 42 USC §1396r. 2006
-
- Rovner BW, Edelman BA, Cox MP, Shmuely Y. The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatry. 1992;149:1390–1392. - PubMed
-
- Semla TP, Palla K, Poddig B, Brauner DJ. Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents. J Am Geriatr Soc. 1994;42:648–652. - PubMed
-
- Shorr RI, Fought RL, Ray WA. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. JAMA. 1994;271:358–362. - PubMed
-
- Briesacher BA, Limcangco MR, Simoni-Wastila L, et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med. 2005;165:1280–1285. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
